{
    "case_number": "CAC-UDRP-107855",
    "time_of_filling": "2025-08-18 14:18:10",
    "domain_names": [
        "tevasbiosimilars.com"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Teva Pharmaceutical Industries Ltd."
    ],
    "complainant_representative": "SILKA AB",
    "respondent": [
        "Tevasbio Tevasbio (tevasbiosimilars)"
    ],
    "respondent_representative": null,
    "factual_background": "",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n<p>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Stephanie Hartung"
    ],
    "date_of_panel_decision": "2025-09-17 00:00:00",
    "informal_english_translation": "<p>The Complainant has evidenced to be the owner of, inter alia, but not limited to, the following trademark registrations:<\/p>\n<p>- word\/device trademark TEVA, European Union Intellectual Property Office (EUIPO), filing&nbsp;No.:&nbsp;000115394, registration date: April 29, 1998, status: active;<\/p>\n<p>- word trademark TEVA, United States Patent and Trademark Office (USPTO), registration&nbsp;No.:&nbsp;1567918, registration date: November 28, 1989, status: active.<\/p>\n<p>Also, the Complainant has substantiated to own since 2009 the domain name &lt;tevabiosimilars.com&gt; which resolves to the Complainant&rsquo;s official website at &ldquo;www.tevabiosimilars.com&rdquo;, used to promote the Complainant&rsquo;s pharmaceutical products and related services internationally.<\/p>\n<p>The disputed domain name was registered on August 1, 2025.<\/p>",
    "decision_domains": {
        "tevasbiosimilars.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}